[Vitamin D-resistant rickets].
Dumas R.
Arch Pediatr. 1999 Jul;6(7):715-9. doi: 10.1016/s0929-693x(99)80352-2.
Hypophosphatemia, hyperphosphaturia, and bisphosphonate treatment are associated with survival beyond infancy in generalized arterial calcification of infancy.
Rutsch F, Böyer P, Nitschke Y, Ruf N, Lorenz-Depierieux B, Wittkampf T, Weissen-Plenz G, Fischer RJ, Mughal Z, Gregory JW, Davies JH, Loirat C, Strom TM, Schnabel D, Nürnberg P, Terkeltaub R; GACI Study Group.
Circ Cardiovasc Genet. 2008 Dec;1(2):133-40. doi: 10.1161/CIRCGENETICS.108.797704.
Hypophosphatemic rickets.
Drezner MK.
Endocr Dev. 2003;6:126-55. doi: 10.1159/000072774.
X-linked hypophosphatemia: Management and treatment prospects.
Lambert AS, Zhukouskaya V, Rothenbuhler A, Linglart A.
Joint Bone Spine. 2019 Nov;86(6):731-738. doi: 10.1016/j.jbspin.2019.01.012. Epub 2019 Jan 31.
Rickets.
Berg EE.
Orthop Nurs. 2004 Jan-Feb;23(1):53-5. doi: 10.1097/00006416-200401000-00014.
[Hyperphosphaturia after intravenous administration of glucose & fructose].
HOENIG V, SCHUCK O, FISCHER O, HOENIGOVA J, PATOVA V.
Acta Med Scand. 1958 May 16;161(1):79-84.
Oncogenous osteomalacia.
Ghosh S, Sinha R, Bandyopadhyay R, Malhotra M.
J Cancer Res Ther. 2009 Jul-Sep;5(3):210-2. doi: 10.4103/0973-1482.57130.
Phosphaturic mesenchymal tumor and related wound problem.
Xiao X, Sun X, Ni P, Huang Y, Xie T.
Medicine (Baltimore). 2018 Oct;97(40):e12507. doi: 10.1097/MD.0000000000012507.
Hypophosphataemic rickets.
Saggese G, Baroncelli GI.
Horm Res. 2000;53 Suppl 3:57-60. doi: 10.1159/000023535.
Tumor-induced osteomalacia.
Hewison M.
Curr Opin Rheumatol. 1994 May;6(3):340-4. doi: 10.1097/00002281-199405000-00017.
